Literature DB >> 2318859

Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen.

S N Roy1, G Mukhopadhyay, C M Redman.   

Abstract

Previous studies indicated that synthesis of B beta chain may be a rate-limiting factor in the production of human fibrinogen since Hep G2 cells contain surplus pools of A alpha and gamma but not of B beta chains, and fibrinogen assembly commences by the addition of preformed A alpha and gamma chains to nascent B beta chains attached to polysomes. To test whether B beta chain synthesis is rate limiting Hep G2 cells were transfected with B beta cDNA, and its effect on fibrinogen synthesis and secretion was measured. Two sets of stable B beta cDNA-transfected Hep G2 cells were prepared, and both cell lines synthesized 3-fold more B beta chains than control cells. The B beta-transfected cells also synthesized and secreted increased amounts of fibrinogen. Transfection with B beta cDNA not only increased the synthesis of B beta chain but also increased the rate of synthesis of the other two component chains of fibrinogen and maintained surplus intracellular pools of A alpha and gamma chains. Transfection with B beta cDNA did not affect the synthesis of albumin, transferrin, or anti-chymotrypsin and had a small inhibitory effect on the synthesis of C-reactive protein. Taken together these studies demonstrate that increased B beta chain synthesis specifically causes increased production of the other two component chains of fibrinogen and that unequal and surplus amounts of A alpha and gamma chains are maintained intracellularly.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318859

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Molecular analysis of afibrinogenemic mutations caused by a homozygous FGA1238 bp deletion, and a compound heterozygous FGA1238 bp deletion and novel FGA c.54+3A>C substitution.

Authors:  Yuka Takezawa; Fumiko Terasawa; Kazuyuki Matsuda; Mitsutoshi Sugano; Aiko Tanaka; Mitsuhiro Fujiwara; Keigo Kainuma; Nobuo Okumura
Journal:  Int J Hematol       Date:  2012-05-26       Impact factor: 2.490

2.  A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.

Authors:  A Tybjaerg-Hansen; B Agerholm-Larsen; S E Humphries; S Abildgaard; P Schnohr; B G Nordestgaard
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

3.  The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers.

Authors:  A E Thomas; F R Green; H Lamlum; S E Humphries
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

4.  Association between Beta-Fibrinogen C148T Gene Polymorphism and Risk of Ischemic Stroke in a North Indian Population: A Case-Control Study.

Authors:  Amit Kumar; Shubham Misra; Pradeep Kumar; Ram Sagar; Kameshwar Prasad
Journal:  Pulse (Basel)       Date:  2016-10-12

5.  Secretion of recombinant human fibrinogen by the murine mammary gland.

Authors:  Stephen P Butler; Tanya K O'Sickey; Susan T Lord; Henryk Lubon; Francis C Gwazdauskas; William H Velander
Journal:  Transgenic Res       Date:  2004-10       Impact factor: 2.788

6.  Genetic Modulation of Plasma Fibrinogen Concentrations: Possible Importance of Interleukin-6.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

7.  Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study.

Authors:  Tahir Bezgin; Cihangir Kaymaz; Özgür Akbal; Fatih Yılmaz; Hacer Ceren Tokgöz; Nihal Özdemir
Journal:  Clin Appl Thromb Hemost       Date:  2016-10-11       Impact factor: 2.389

8.  Beneficial effects of the addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions.

Authors:  Hetal D Shah; Keyur H Parikh; Milan C Chag; Urmil G Shah; Hemang A Baxi; Anish H Chandarana; Ajay M Naik; Joyal N Shah; Sangeeta Iyer; Kanan J Shah; Ramesh K Goyal
Journal:  Exp Clin Cardiol       Date:  2007

9.  Fibrinogen beta-chain -C148T polymorphism is associated with increased fibrinogen, C-reactive protein, and interleukin-6 in patients undergoing coronary artery bypass grafting.

Authors:  Ewa Wypasek; Ewa Stepien; Malgorzata Kot; Dariusz Plicner; Boguslaw Kapelak; Jerzy Sadowski; Anetta Undas
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

10.  Relationship between fibrinogen level and its regulatory gene with Alzheimer's disease and vascular dementia.

Authors:  Yanan Sun; Qi Li; Wei Liu; Benshu Zhang
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.